These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35734087)

  • 1. COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004).
    Munoz FM; Posavad CM; Richardson BA; Badell ML; Bunge K; Mulligan MJ; Parameswaran L; Kelly C; Olsen-Chen C; Novak RM; Brady RC; Pasetti M; DeFranco E; Gerber JS; Shriver M; Suthar MS; Moore K; Coler R; Berube B; Kim SH; Piper JM; Miller A; Cardemil C; Neuzil KM; Beigi R;
    medRxiv; 2022 Jun; ():. PubMed ID: 35734087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn.
    Munoz FM; Posavad CM; Richardson BA; Badell ML; Bunge KE; Mulligan MJ; Parameswaran L; Kelly CW; Olson-Chen C; Novak RM; Brady RC; Pasetti MF; Defranco EA; Gerber JS; Shriver MC; Suthar MS; Coler RN; Berube BJ; Kim SH; Piper JM; Miller AM; Cardemil CV; Neuzil KM; Beigi RH;
    Vaccine; 2023 Aug; 41(36):5296-5303. PubMed ID: 37451878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced maternal immunity and vertical transfer of immunity against SARS-CoV-2 variants of concern with COVID-19 exposure or initial vaccination in pregnancy.
    Boelig RC; Chaudhury S; Gromowski GD; Mayer S; King J; Aghai ZH; Bergmann-Leitner E
    Front Immunol; 2023; 14():1216410. PubMed ID: 37753075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women.
    Atyeo C; Shook LL; Nziza N; Deriso EA; Muir C; Baez AM; Lima RS; Demidkin S; Brigida S; De Guzman RM; Burns MD; Balazs AB; Fasano A; Yonker LM; Gray KJ; Alter G; Edlow AG
    Am J Obstet Gynecol; 2023 Jan; 228(1):68.e1-68.e12. PubMed ID: 35868417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Adverse Reactions, Antibody Patterns, and 12-month Outcomes in the Mother-Infant Dyad After COVID-19 mRNA Vaccination in Pregnancy.
    Cassidy AG; Li L; Golan Y; Gay C; Lin CY; Jigmeddagva U; Chidboy MA; Ilala M; Buarpung S; Gonzalez VJ; Basilio E; Duck M; Murtha AP; Wu AHB; Lynch KL; Asiodu IV; Prahl MK; Gaw SL
    JAMA Netw Open; 2023 Jul; 6(7):e2323405. PubMed ID: 37450302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccine induced poor neutralization titers for SARS-CoV-2 omicron variants in maternal and cord blood.
    Govindaraj S; Cheedarla N; Cheedarla S; Irby LS; Neish AS; Roback JD; Smith AK; Velu V
    Front Immunol; 2023; 14():1211558. PubMed ID: 37465682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection.
    Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Briker SM; Triebwasser JE; Gerber JS; Morris JS; Weirick ME; McAllister CM; Hensley SE; Puopolo KM
    JAMA Netw Open; 2022 Nov; 5(11):e2240993. PubMed ID: 36350652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G Levels After the Pfizer-BioNTech Booster Dose for Coronavirus Disease 2019 (COVID-19) Vaccination During the Second Trimester of Pregnancy.
    Kugelman N; Nahshon C; Shaked-Mishan P; Kleifeld S; Cohen N; Sher ML; Zahran H; Barsha H; Assaf W; Shalabna E; Stein N; Lavie O; Kedar R; Riskin-Mashiah S
    Obstet Gynecol; 2022 Aug; 140(2):187-193. PubMed ID: 35852268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Bivalent Booster in Pregnancy: Maternal and Neonatal Antibody Response to Omicron BA.5, BQ.1, BF.7 and XBB.1.5 SARS-CoV-2.
    Chen WC; Hu SY; Shen CF; Chuang HY; Ker CR; Shen CJ; Cheng CM
    Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection.
    Hyun H; Jang AY; Park H; Heo JY; Seo YB; Nham E; Yoon JG; Seong H; Noh JY; Cheong HJ; Kim WJ; Yoon SY; Seok JH; Kim J; Park MS; Song JY
    Front Immunol; 2023; 14():1131229. PubMed ID: 36960070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional study.
    Fong CH; Zhang X; Chen LL; Poon RW; Chan BP; Zhao Y; Wong CK; Chan KH; Yuen KY; Hung IF; Yuen JKY; To KK
    EBioMedicine; 2023 Feb; 88():104446. PubMed ID: 36706582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine.
    Furukawa K; Tjan LH; Kurahashi Y; Sutandhio S; Nishimura M; Arii J; Mori Y
    JAMA Netw Open; 2022 May; 5(5):e2210780. PubMed ID: 35532938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants.
    Cardemil CV; Cao Y; Posavad CM; Badell ML; Bunge K; Mulligan MJ; Parameswaran L; Olson-Chen C; Novak RM; Brady RC; DeFranco E; Gerber JS; Pasetti M; Shriver M; Coler R; Berube B; Suthar MS; Moreno A; Gao F; Richardson BA; Beigi R; Brown E; Neuzil KM; Munoz FM;
    Pediatrics; 2024 Mar; 153(3):. PubMed ID: 38332733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Vaccine Booster Elicits Robust Prolonged Maternal Antibody Responses and Passive Transfer Via The Placenta And Breastmilk.
    Marshall NE; Blanton MB; Doratt BM; Malherbe DC; Rincon M; True H; McDonald T; Beauregard C; Adatorwovor R; Messaoudi I
    bioRxiv; 2022 Nov; ():. PubMed ID: 36482972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy.
    Kugelman N; Nahshon C; Shaked-Mishan P; Cohen N; Sher ML; Gruber M; Marom I; Zolotarevsky A; Lavie O; Damti A; Zilberlicht A; Bardicef M; Kedar R
    JAMA Pediatr; 2022 Mar; 176(3):290-295. PubMed ID: 34932066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022.
    Canaday DH; Oyebanji OA; White EM; Bosch J; Nugent C; Vishnepolskiy I; Abul Y; Didion EM; Paxitzis A; Sundheimer N; Ragavapuram V; Wilk D; Keresztesy D; Cao Y; St Denis K; McConeghy KW; McDonald LC; Jernigan JA; Mylonakis E; Wilson BM; King CL; Balazs AB; Gravenstein S
    MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(4):100-106. PubMed ID: 36701254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants.
    Qu P; Faraone JN; Evans JP; Zheng YM; Carlin C; Lozanski G; Saif LJ; Oltz EM; Gumina RJ; Liu SL
    bioRxiv; 2022 Jul; ():. PubMed ID: 35898337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mRNA Covid-19 vaccines in pregnancy: A systematic review.
    Pratama NR; Wafa IA; Budi DS; Putra M; Wardhana MP; Wungu CDK
    PLoS One; 2022; 17(2):e0261350. PubMed ID: 35108277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durability of immune responses to mRNA booster vaccination against COVID-19.
    Arunachalam PS; Lai L; Samaha H; Feng Y; Hu M; Hui HS; Wali B; Ellis M; Davis-Gardner ME; Huerta C; Bechnak K; Bechnak S; Lee M; Litvack MB; Losada C; Grifoni A; Sette A; Zarnitsyna VI; Rouphael N; Suthar MS; Pulendran B
    J Clin Invest; 2023 May; 133(10):. PubMed ID: 36951954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.